Bone marrow-derived mesenchymal stem cells therapy (Institute Of Basic Medicine, Chinese Academy Of Medical Sciences)

骨髓原始间充质干细胞（中国医学科学院基础医学研究所）

Report date: 2023/01/12 15:47:38

Base Information

Drug NameBone marrow-derived mesenchymal stem cells therapy (Institute Of Basic Medicine, Chinese Academy Of Medical Sciences)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesInstitute Of Basic Medicine, Chinese Academy Of Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitute Of Basic Medicine, Chinese Academy Of Medical Sciences

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A